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Abstract. The adhesive xtracellular matrix glycopro- 
tein fibronectin (FN) is thought o play an important 
role in the cell migration associated with wound heal- 
ing. Immunolocalization studies show abundant FN in 
healing wounds; however, these studies cannot define 
the cellular site(s) of FN synthesis, nor do they distin- 
guish the different and potentially functionally distinct 
forms of FN that can arise from alternative splicing of 
the primary gene transcript. To examine these ques- 
tions of FN synthesis and splicing during wound heal- 
ing, we have performed in situ hybridization with 
segment-specific probes on healing wounds in adult rat 
skin. We find that the FN gene is expressed at in- 
creased levels after wounding both in the cells at the 
base of the wound and in subjacent muscle and dermis 
lateral to the wound. Interestingly, however, the pattern 
of splicing of FN mRNA was different in these areas. 
In adjacent dermis and muscle, the splicing pattern re- 
mains identical with that seen in normal adult rat 
skin, with two of the three spliced segments (EIIIA 
and EIIIB) excluded from FN mRNA. In contrast, 
these two segments are included in the FN mRNA 
present in the cells at the base of the wound. As a re- 
sult, the mRNA in this region is spliced in a pattern 
identical with that found during early embryogenesis. 
The finding that the pattern of FN splicing during 
wound healing resembles an embryonic pattern sug- 
gests that alternative splicing may be used during 
wound healing as a mechanism to generate forms of 
FN that may be functionally more appropriate for the 
cell migration and proliferation associated with tissue 
repair. 
T 
hE ability to repair damaged tissue, wound healing, 
represents an important response to injury that is com- 
mon to all complex organisms. Just as in embyronic 
development, this process involves cell proliferation, migra- 
tion, and differentiation of a number of different cell types 
(Clark and Henson, 1988). It therefore seems likely that 
wound healing might share many of the molecular mecha- 
nisms used during development. A number of studies have 
examined the role of the adhesive xtracellular matrix glyco- 
protein fibronectin (FN),~ which has been shown to play an 
important role in embryonic ell migration. FN promotes 
cell migration in culture (Ali and Hynes, 1978; Rovasio et 
al., 1983) and is present in the embryo associated with many 
different cell migrations (Critchley et al., 1979; Kurkinen et 
al., 1979; Newgreen and Thiery, 1980; Mayer et al., 1981; 
Heasman et al., 1981; Duband and Thiery, 1982; Thiery et 
al., 1982; Linask and Lash, 1986; Kitten et al., 1987; 
Dufour et al., 1988). In addition, antibodies to FN (Boucaut 
et al., 1984; Poole and Thiery, 1986) or to cell surface recep- 
tors of the integrin glycoprotein family (Bronner-Fraser, 
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1. Abbreviations used in this paper: EIIIA and EIIIB, spliced segments of 
type III repeats; FN, fibronectin; nt, nucleotide; V, nonhomologous seg- 
ment lying between two type 11I repeats. 
1985, 1986) can block migration when injected into the in- 
tact embryo. 
FN is expressed at high levels in healing wounds (Kurki- 
nen et al., 1980; Grinnell et al., 1981; Clark et al., 1982a, 
b) and is derived from two sources: plasma FN (pFN), which 
is present in the exudate from damaged blood vessels; and 
"cellular" FN, which is synthesized locally in the wound tis- 
sue (Clark et al., 1983). It seems likely that FN plays an im- 
portant role in wound healing as it appears to be involved in 
the migration in vitro of four major cell types that migrate 
into the area of the wound. Fibroblasts and epidermal cells 
(keratinocytes) are stimulated to migrate by FN (Ali and 
Hynes, 1978; Donaldson and Mahan, 1983; Takashima et 
al., 1986). FN is a chemoattractant stimulus for endothelial 
cells (Bowersox and Sorgente, 1982), whereas FN fragments 
are chemotactic for macrophages (Norris et al., 1982; Clark 
et al., 1988). 
The antibody localization methods used to demonstrate 
FN in healing tissue do not allow a more precise definition 
of the role of FN. First, identification in wounds of an ex- 
tracellular molecule does not distinguish between local 
secretion and extravasation from plasma. Second, it is likely 
that multiple forms of FN are present, as the primary FN 
gene transcript can be alternatively spliced in three regions. 
These multiple forms may each play different roles in cell 
movement, but can not be distinguished by the antibodies 
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presently used to identify FN in wounds, which were pre- 
pared against intact FN and will therefore recognize pitopes 
present on all forms of FN. The potential molecular hetero- 
geneity resulting from alternative splicing of mRNA for rat 
FN is illustrated in Fig. 1. The three spliced segments are 
shown; two, designated EIIIA and EIIIB, represent part of 
the series of so-called type III repeats that constitute he cen- 
tral portion of the molecule while the third, V, represents a 
nonhomologous segment lying between two type III repeats 
(Hynes, 1985). EIIIA and EIIIB can either be included or 
excluded, whereas the V region in the rat can be partially or 
completely included (depending on the choice of splice site 
used) to generate inserts of 95 or 120 amino acids (Fig. 1) 
(Schwarzbauer t al., 1983; Hynes, 1985; Kornblihtt et al., 
1985; Paul et al., 1986; Schwarzbauer tal., 1987; Norton 
and Hynes, 1987). As a result of this splicing, 12 potential 
forms of rat FN can be generated. At least in the human and 
chicken, the potentially excluded V region contains cell 
adhesion sites (Humphries et al., 1986, 1987, 1988), sug- 
gesting that some of these different forms may be function- 
ally distinct from each other. 
In this study, we have addressed these questions of synthe- 
sis and splicing during wound healing by using in situ hybrid- 
ization with probes that either recognize all forms of FN 
mRNA or that are specific for the different spliced variants. 
We find that the level of FN mRNA present in wounds is 
much greater than that found in normal adult rat skin. Also, 
the FN mRNA in the wound shows a pattern of splicing 
different from that in normal skin and similar to that found 
in the early embryo. As well as allowing a more precise 
definition of the patterns of FN synthesis in wound repair, 
these results uggest that FN splicing is used as a mechanism 
to create functionally appropriate forms of FN that facilitate 
the process of wound healing. 
Materials and Methods 
Preparation of 1Issue 
4-ram punch biopsy lesions were made in the flanks of female adult rats 
(150-200 g, CD rats, Charles River Laboratories, Inc., Wilmington, MA), 
which had been anaesthetised with 25 mg/kg ketamine HCI and 5 mg/kg 
xylazine. At intervals (1, 2, 4, 7 and 14 d) after biopsy, rats were killed and 
wound sites were excised. Individual rats were used for each wound and 
control tissue was taken from unwounded rats. 
Excised wound tissue was immersed in ice-cold 5% glacial acetic acid, 
4% formaldehyde, and 85% ethanol for 15-30 min and bisected; fixation 
was continued for a total of 3-4 h. Tissues were then dehydrated in ascend- 
ing concentrations of ethanol and embedded in paraffin (Paraplast Xtra; 
Polysciences, Inc., Warrington, PA). 7-tim microtome sections were mount- 
ed on glass slides that had been pretreated with 10% TESPA (3-amino- 
propyl-triethoxysilane) i  toluene for 1 h at 80°C, washed in toluene, and 
activated by immersion in 4% formaldehyde for 1 h (after Berger, 1986, 
modified as suggested by Dr. D. Melton, Harvard University, Cambridge, 
MA). The slides were left on a warm plate at 45°C overnight before use. 
Preparation of Probes for In Situ Hybridization 
To synthesize the probes used in this study, fragments of DNA from larger 
clones and corresponding either to a region in the type-I repeats near the 
COOH-terminal end of FN always included in the final transcript, or to parts 
of the EIIIA-, EIIIB-, or V95-spliced regions were subeloned into pGEM 
plasmids to allow the synthesis of both sense and antisense probes. The 
lengths of the DNA inserts were 270, 213, 209, and 250 nucleotides (nt) for 
the segments C, EIIIA, EIIIB, and V95, respectively (see Fig. 1). 
Single-stranded RNA probes labeled to a specific activity of '~10 s 
cpm//xg with [35S]-UTP were synthesized using a commercially available 
transcription kit (Promega Biotec, Madison, WI). After the synthesis, all 
probes were purified on denaturing polyacrylamide g ls and used without 
any reduction in length by alkaline hydrolysis (Angerer et al., 1987). 
In Situ Hybridization 
Prehybridization a d hybridization were performed as previously described 
(ffrench-Constant d Hynes, 1988). In brief, slides were dewaxed and se- 
quentially passed through 0.2 M HCI, 1 #g/ml proteinase K, 0.2% glycine, 
4% paraformaldehyde, and 1/200 (vol/vol) acetic anhydride in 0.1 M 
triethanolamine, pH 8.0, before addition of the hybridization mixture. Hy- 
bridization buffer (50% deionized formamide, 10% dextran sulfate, 0.3 M 
NaCI, 10 mM Tris [pH 7.6], 5 mM EDTA, 0.02 % [wt/vol] Ficol1400, 0.02 % 
[wt/vol] polyvinylpyrolidone, 0.02% [wt/vol] BSA, 10 mM DTT, 100 ~tg/ml 
yeast RNA, and 500 #M nonradiolabeled thio-UTP) containing the appro- 
priate probe at a concentration f 0.3/~g/ml per kb probe complexity was 
adjusted to a pH of 6.0 and placed on the sections. This probe concentration 
is the same as that used in our studies on FN mRNA distribution i  chicken 
embryos (ffrench-Constant and Hynes, 1988, 1989). In those studies we 
found that higher probe concentrations produced higher backgrounds with- 
out any further increase in signal (unpublished observations). 0.3 #g/ml per 
kb probe complexity therefore r presents a uitable probe concentration that 
is sufficient to saturate target FN mRNAs even in early embryonic cell types 
that express abundant FN mRNA (ffrench-Constant d Hynes, 1988), and 
for this reason it was chosen for the present study on v,~und healing. After 
hybridization overnight at 50°C, slides were rinsed in 50% formamide, 2 x 
SSC, 10 mM DTT at 50°C, digested with 10 ~tg/ml RNase A (type ILIA; 
Sigma Chemical Co., St. Louis, MO), and then washed in 50% formamide, 
2× SSC, 10 mM IYI'T at 65°C as before. Slides were then dried, dipped 
in Kodak NTB-2 emulsion (diluted 1:1 in water) and exposed for 7 d at 
-20°C, after which time they were developed in Kodak D19, fixed, stained 
with 0.02 % toluidine blue, and mounted with DPX mountant. Sections were 
viewed on Zeiss Universal or Axiophot microscopes equipped with 
brightfield and darkfield optics, and photographed on Tech Pan film at 
85ASA. 
Results 
FN Gene Expression and Splicing in Normal Skin 
To determine the localization ofFN mRNA in rat tissue sec- 
tions, we hybridized these sections with an antisense 3~S-la- 
beled RNA probe synthesized asdescribed in Materials and 
Methods. The template used was a 270-nt segment corre- 
sponding to a region in the type-I repeats near the COOH- 
terminal end of the molecule (Fig. l). This region is included 
in all known forms ofFN mRNA and the antisense probe can 
therefore be used to detect all the different spliced variants 
of FN mRNA. 
When this probe (designated FN-C) was hybridized to sec- 
tions of normal skin, specific labeling of scattered cells was 
observed in the deep (reticular) dermis and in the subjacent 
adipose tissue (Fig. 2). Often, labeled cells were found sur- 
rounding the base of hair follicles (not shown). In addition, 
labeled cells were seen in a narrow band just superficial to 
the striated muscle layer (panniculus carnosus) and occa- 
sionally between fibers within this muscle itself (Fig. 2). 
More extensive labeling was present in the thin layer of con- 
nective tissue deep to the muscle layers (Fig. 2). The 
epidermis and superficial (papillary) dermis were not la- 
beled. The specificity of this hybridization pattern was 
confirmed by the absence of labeling with a sense probe syn- 
thesized from the same construct (data not shown). 
We next determined the splicing pattern of FN mRNA in 
normal skin. Sections were incubated with antisense probes 
synthesized using DNA fragments from the EIIIA, EIIIB, 
and V95 regions as templates (probes designated FN-EIIIA, 
FN-EIIIB, and FN-V95, as shown in Fig. 1). These probes 
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Probe Constructs 
I I 
FN-EIIIB FN-EIIIA FN-V FN-C 
I-4 I-I I-'4 I-4 
SH SH 
N'-12 CCCH 
/ 
÷CE12  v120 
I 0 Oq CFI 
I Type II . , , [~ /~ ~ V95 
[Type Ill CR [ ~ .  V 0 
II Figure 1. A diagrammatic representation of rat FN 
showing the three regions of alternative splicing 
and illustrating the potential heterogeneity that can 
be generated by this mechanism. The four probes 
used in this study are shown; ote that the V95 
probe cannot distinguish the V95 and V120 forms 
of FN. 
were of similar length (213, 209, and 250 nt, respectively) 
to the 270-nt FN-C probe. As shown in Fig. 1, the V95 region 
is included in the mRNA encoding both the 95- and 120- 
amino acid insert, so these two forms cannot be distin- 
guished by the FN-V95 probe. 
No significant labeling was found with the FN-EIIIA or 
FN-EIIIB probes, whereas the FN-V95 probe labeled normal 
skin in a pattern similar to that seen with e FN-C probe 
(Fig. 2). No labeling of sections of normal skin was seen with 
a sense probe synthesized from the FN-V95 construct (not 
shown). All these probes are of similar length and specific 
activity and were used at the same concentration i the hy- 
bridization reactions. The absence of labeling with FN- 
EIIIA and FN-EIIIB indicates, therefore, that the majority 
of the FN mRNA that is present in scattered cells within the 
dermis and muscle of normal adult rat skin lacks these two 
segments. In contrast, the V segment is included in this FN 
mRNA. However, the semiquantitative nature of in situ hy- 
bridization does not allow an accurate determination of the 
extent of this inclusion. 
Figure 2. Four closely adjacent sections of normal adult rat skin hybridized with the FN-C, FN-EIIIA, FN-EIIlB, and FN-V probes as 
indicated, and then viewed with darkfield optics (B-E). A representative section viewed with brightfield optics is shown (.4). Scattered 
labeling with FN-C is seen in the reticular dermis (DE), whereas the epidermis (El)) is unlabeled. Labeling is also seen on either side 
of the striated muscle layer (M) below the dermis, and occasionally within the muscle itself. The segment-specific probes how an identical 
pattern of labeling with FN-V, but no labeling with FN-EIIIA or FN-EIIIB, suggesting that the FN mRNA in normal rat skin is A-B-V +. 
Bar, 200 ~tm. 
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l~gure 3. A section through one edge of a 2--d wound, hybridized with FN-C and viewed with brightfield (A) and darkfield (B) optics. 
Extensive scattered labeling is seen in the dermis (DE) and muscle (M). Labeling is also seen at the base (hollow arrows) and edge (arrows) 
of the wound as well as in the uninjured d rmis lateral to the wound (DE). Note that the epidermal cells (EP) have not yet started to migrate 
centrally. They will migrate down the edge and over the base of the wound during healing. Bar,200 #m. 
FN Gene Expression after Wounding 
Skin punch biopsy wounds provide a well-defined and repro- 
ducible experimental model (Clark and Henson, 1988). 
Wounding to the level of the deep reticular dermis is followed 
immediately by the coagulation of blood and extravasated 
plasma fibrinogen and FN, forming a gel that serves as provi- 
sional matrix. This matrix is invaded initially (within hours) 
by neutrophils and later by monocytes/macrophages; among 
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Figure 4. A section through one 
edge of a 4-d wound hybridized 
with FN-C and viewed as in Fig. 
3. Epidermal cells (EP) have 
now migrated into the base of the 
wound. As in 2-d wounds, labeled 
cells are found in the lateral der- 
mis (DE), muscle (M), base (hol- 
low arrows), and edges (arrows) 
of the wound. Note, however, that 
the labeling of the granulation tis- 
sue (GT) at the base is more in- 
tense and widespread than was 
seen at 2 d. Bar, 200 #m. 
their many functions, these inflammatory cells debride dead 
tissue and phagocytose bacteria. Epidermal keratinocytes at
the wound edge proliferate and migrate inwardly (centripe- 
tally) over the provisional matrix, participate in the genera- 
tion of a new basement membrane, and restore a complete 
epidermis within 7 d. Inflammatory cells decline in number 
(over days) as fibroblasts and endothelial cells invade the 
wound bed, forming highly vascular granulation tissue. 
Granulation tissue, in turn, is remodeled and, with the laying 
down of interstitial collagens, is transformed into dense scar 
tissue (over weeks). 
Healing wound sites were examined l, 2, 4, 7, and 14 d 
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after wounding, and the distribution of FN mRNA was deter- 
mined by hybridization with the FN-C probe. At 1 and 2 d 
(day 2, shown in Fig. 3) the wound, which extended eep 
into the reticular dermis, was covered with a desiccated 
blood clot. FN-C labeling was seen in cells that formed a 
band in the wound bed immediately beneath this clot. In ad- 
dition, many more labeled cells were seen i the neighboring 
dermis and subjacent striated muscle than had been observed 
in normal skin (compare Fig. 3 with Fig. 2). Two differences 
were observed between the labeling of the wounds at 1 and 
2 d. First, labeling was more intense and extensive on day 
2. Second, at 2 d, labeling was particularly marked in cells 
immediately beneath the wound in the region over which the 
epidermal cells will migrate centripetally tocover the wound 
(Fig. 3). 
At 4 d (Fig. 4) the epidermis had migrated centrally to be- 
gin to cover the wound. Widespread and intense cell labeling 
was seen in the granulation tissue which had now formed at 
the base of the wound. As at 2 d, numerous labeled cells were 
seen in the neighboring dermis and muscle (Fig. 4), extend- 
ing a greater distance from the wound than at 2 d. In addi- 
tion, labeled cells continued to be present in the superficial 
dermis at the edge of the wound (Fig. 5). In contrast, how- 
ever, the epidermal cells themselves were unlabeled at all 
times (Figs. 4 and 5). 
By 7 d (Fig. 6) the wound area was smaller, reflecting some 
degree of wound contraction, and, in addition, the wound 
was now closed, being completely covered by epidermal 
cells. The underlying ranulation tissue appeared as a dis- 
crete triangular zone rich in blood vessels and newly depos- 
ited collagen. Cells of the granulation tissue were still in- 
tensely labeled, but labeling was now less extensive in 
neighboring dermis and muscle than at earlier intervals 
(compare Fig. 6 with Figs. 3 and 4). 
At the latest ime studied, 14 d (not shown), labeling of 
granulation tissue (now still further reduced in area) was 
considerably less intense than at 7 d and the extent of la- 
beling in adjacent tissues was reduced to normal evels. No 
labeling of any of these regions at any time during healing 
was seen with a sense probe synthesized from the FN-C tem- 
plate, confirming the specificity of the labeling. 
These results with the FN-C probe therefore demonstrate 
increased FN mRNA levels after wounding in two locations; 
in the base and edge of the wound, and in cells present in 
the uninjured dermis and muscle 1-2 mm lateral to the 
wound. 
FN Splicing after Wounding 
The pattern of alternative splicing of FN mRNA in these 
wounds was determined by hybridizing sections with e FN- 
EIIIA, FN-EIIIB, and FN-V95 probes (Fig. 7). As in normal 
skin, FN-V95 labeled wound sections in a pattern identical 
with that seen with FN-C at all of the time intervals examined 
(compare Fig. 7 with Fig. 4). In contrast with our results in 
normal skin, however, labeling was now also found with the 
FN-EIIIA and FN-EIIIB probes at all the different stages ex- 
amined (shown for the 4-d wound in Fig. 7). This labeling 
was largely restricted to the granulation tissue at the base of 
the wound and to the cells of the superficial dermis at the 
edge of the wound over which epidermal cell migration oc- 
curs. Unlike the results with FN-C or FN-V95, a significantly 
lower level of labeling was seen in the muscle and in the 
dermis lateral to the wound (compare Figs. 7 and 8 with Fig. 
4). In addition to this restricted distribution of FN-EIIIA and 
FN-EIIIB labeling, we found that the labeling with FN- 
EIIIA was always more intense than that with FN-EIIIB (Fig. 
7). As these two probes were virtually identical in length, 
Figure 5. A section of a 4-d wound shown ata higher magnification than that of Fig. 4 to demonstrate the migrating epidermal cells dissecting 
between the desiccated clot and wound base. The section has been hybridized with FN-C and viewed with brightfield (A) and darkfield 
(B) optics as in Fig. 3. Note that the section shows the opposite edge of a wound from that in Figs. 3 and 4, and the direction of migration 
is therefore left to right. Intense labeling is seen in the granulation tissue (GT) under the migrating epidermal cells (EP), and also in th  
immediately adjacent dermal cells (DE). Note, however, that the epidermal cells themselves are unlabeled (asterisks). The low level of 
labeling seen above the epidermal cells represents nonspecific binding of the FN-C probe to the clot covering the wound, and was also 
observed in the sense controls (not shown). Bar, 50 ~m. 
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Figure 6. A section through an entire day 7 wound hybridized and viewed as in Figs. 3 and 4. The smaller wound area than that seen 
at 4 d reflects wound contraction between the two times. The granulation tissue (GT) (blood vessel indicated by a bold arrow) remains 
intensely labeled. Labeled cells in the muscle (M) and dermis (DE) are less numerous than at 2 and 4 d. Note that the epidermis (EP) 
now completely covers the wound and remains unlabeled. Bar, 200 #m. 
ffrench-Constant et al. Fibronectin Splicing in Wounds 909 
specific activity and concentration, these data suggest that 
EIIIB ÷ forms of FN mRNA are less abundant than EIIIA ÷ 
forms in the area of the wound. 
No specific labeling was seen when the sections of wound- 
ed skin were hybridized with sense probes synthesized from 
the FN-EIIIA, FN-EIIIB, and FN-V constructs, confirming 
the specificity of these segment-specific probes (data not 
shown). 
The observed restriction of expression of EIIIA and EIIIB 
in FN mRNA after wounding could result either from a 
splicing difference or from an overall increase in the level of 
all variants of FN mRNA so that a previous undetectable 
level of EIIIA + or EIIIB ÷ FN mRNA was now sufficient o 
produce a hybridization signal. To confirm the appearance 
of a change in alternative splicing we hybridized adjacent 
sections ofa 4-d wound with FN-C, FN-EIIIA, or FN-EIIIB, 
and then exposed the sections to autoradiographic emulsion 
for different periods of time such that the level of labeling 
in the wound bed and edges was as great or greater with FN- 
EIIIA or FN-EIIIB than with FN-C (Fig. 8). If the cells in 
the adjacent dermis and muscle contain the same proportion 
of EIIIA and EIIIB in their FN mRNA as do those at the 
wound base and edges, they should now also label as, or 
Figure 7. Three closely adjacent sections through the edge of the 
same 4-d wound as that shown in Fig. 4, illustrating the appearance 
of EIIIA + and EIIIB + FN mRNA after wounding. The sections 
were hybridized with the segment-specific probes FN-V95, FN- 
EIIIA, and FN-EIIIB as indicated and viewed with darkfield optics. 
FN-V95 labels in a manner identical to FN-C (shown in Fig. 4), 
with intense labeling both of the wound base and edge (hollow ar- 
row) as well as of adjacent dermis (DE) and muscle (M). FN-EIIIA 
also labels the base and edges of the wound, but shows a more re- 
stricted distribution with little labeling of the muscle (M) and of 
the dermis (DE). FN-EIIIB labels the same areas as FN-EIIIA but 
with a lower intensity. Note that the connective tissue layer under 
the muscle (arrowheads) remains A-B-V + after wounding. Bar, 
500 #m. 
Figure 8. Three closely adjacent sections through the base of a 4-d wound hybridized with FN-C, FN-EIIIA, and FN-EIIIB, exposed for 
1, 2, and 7 d, respectively, and then viewed with darkfield optics (B-D). A representative section is shown in brightfield optics (.4). As 
explained in the text, the absence of labeling in the dermis (DE) and muscle (M) with FN-EIIIA and FN-EIIIB in the presence of more 
intense labeling in the base of the wound (hollow arrow) with these probes than with the FN-C probe shows that the restricted exoression 
of EIIIA and EIIIB after wounding reflects a difference in RNA splicing between the two regions. Bar, 300 #m. 
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more, intensely with FN-EIIIA or FN-EIIIB as with FN-C. 
However, in these experiments he restricted istribution of 
EIIIA and EIIIB was still seen, with little labeling outside 
the base and edges of the wound (Fig. 8). We conclude, 
therefore, that he observed pattern of labeling with the splice 
segment-specific probes reflects a splicing difference in 
which EIIIA and EIIIB are included in the FN mRNA at the 
base and sides of the wound to a greater degree than they are 
in normal skin or in cells more distant from the wound. 
Discussion 
To determine the patterns ofFN gene expression and splicing 
in healing wounds, we performed insitu hybridization on tis- 
sue sections of normal rat skin and wounds at different times 
during healing, using probes that recognize ither total FN 
mRNA or mRNA containing the individual spliced seg- 
ments. We found a low but significant level of FN mRNA in 
normal skin localized to scattered individual cells in the re- 
ticular dermis and to cells adjacent to and within the pannic- 
ulus carnosus. In wounded skin, by contrast, extensive x- 
pression of FN mRNA was found at the base and edges of 
the wound, extending into the adjacent uninjured ermis and 
to the underlying muscle. This increased level of FN mRNA 
was evident within 1 d after wounding, with the highest levels 
seen at the fourth and seventh day. Analysis of the splicing 
pattern showed that this FN mRNA was spatially heteroge- 
neous. Cells at the base and edges of the wound expressed 
mRNA that included both of the alternatively spliced EIIIA 
and EIIIB regions; in contrast, mRNA expression i  adja- 
cent dermis and muscle showed the same splicing pattern as 
that seen in normal skin; that is, EIIIA and EIIIB were 
largely excluded. Thus, (a) wounding induces increased lev- 
els of FN mRNA both directly beneath the wounded area and 
in adjacent dermal tissue; and (b) the pattern of splicing of 
FN mRNA locally in the wound bed, but not that in contigu- 
ous but more distant sites, differs from that in normal skin. 
These results are consistent with previous immunolocal- 
ization studies of FN in normal and wounded skin. Studies 
in normal rat skin have demonstrated FN surrounding hair 
follicles in the dermis (Couchman et al., 1979) and reported 
either a low or undetectable level of FN in the normal epider- 
mal basement membrane (Couchman et al., 1979; Clark et 
al., 1983). After wounding, FN levels are reported to rise 
substantially atthe base and edges of the wound (Grinnell et 
al., 1981; Clark et al., 1982a, b). At least some of this 
FN is apparently synthesized by cells in the immediate vicin- 
ity of the wound, as studies using mice in which well-healed 
transplants ofrat skin were wounded have shown that locally 
synthesized (rat) FN is present in the zone of healing (Clark 
et al., 1983). These studies also showed that rat FN was less 
abundant than the mouse pFN for the first 4 d after wounding 
(Clark et al., 1983). However, our results show a dramatic 
early increase in FN mRNA at the base of the wound, and 
in the dermis forming the edge of the wound. This suggests 
that locally produced FN is present from the earliest stages 
of healing. Moreover, this locally produced FN contains 
spliced segments not present in the pFN that constitutes the 
majority form of FN at these early stages. We hypothesize 
that these new forms of FN may perform qualitatively differ- 
ent functions. 
A central event in healing skin wounds is the inward migra- 
tion of epidermal cells from the wound edges to cover the in- 
jured surface. As judged by immunohistochemistry, hese 
migrating cells are underlain by an irregular band of fibrin 
and FN (Clark et al., 1982a; Clark et al., 1983; Dvorak et 
al., 1984). This is in contrast o the situation in normal, 
uninjured skin where the epidermal basal amina contains lit- 
tle or no fibrin or FN (Couchman et al., 1979). The source 
of the FN associated with migrating keratinocytes has not 
been established, and it could be derived from plasma or 
from local synthesis by epidermal or dermal cells. 
A striking feature observed in our study was the expres- 
sion of FN by cells disposed at the base and edges of the 
wound just beneath the epidermis; this FN mRNA expres- 
sion preceded the inward migration of epidermal cells that 
eventually covered the wound. FN-coated glass coverslips 
inserted under the skin of newts are reported to promote 
epidermal cell migration (Donaldson and Mahan, 1983). 
Epidermal cells also express a 140-kD FN receptor similar 
to fibroblast FN receptors (Toda et al., 1987; Grinnell et al., 
1987). It seems likely that expression of this epidermal cell 
receptor is increased after wounding, as these cells show in- 
creased adhesion to FN while migrating over a wound base 
(Takashima et al., 1986) and the Arg-Gly-Asp-Ser (RGDS) 
peptide, which inhibits the binding of FN by the integrin 
receptors (Ruoslahti and Pierschbacher, 1987) can prevent 
epidermal cell migration after wounding (Donaldson et al., 
1987). Together, these findings uggest that he cells contain- 
ing FN mRNA at the wound edges ynthesize a matrix which 
forms a pathway of FN. This pathway may then be followed 
by migrating epidermal cells expressing integrin receptors 
that bind this FN. Our observation that neither migrating nor 
normal epidermal cells express significant levels of FN 
mRNA suggests that they are not responsible for the synthe- 
sis of the FN over which they migrate. Instead, without com- 
petition by endogenous FN, receptors on epidermal cells 
may then be maximally responsive toFN encountered within 
the pathway. 
Our finding that epidermal cells migrating over the wound 
bed contain little or no FN mRNA in vivo is in contrast with 
in vitro studies, in which these cells synthesize FN (Alitalo 
et al., 1982; Clark et al., 1985; Kariniemi et al., 1982; 
O'Keefe t al., 1984, 1987; Kubo et al., 1987), and illustrates 
the caution required when extrapolating from in vitro models 
of wound healing to the in vivo situation. It is important, 
therefore, to establish the source(s) of FN in vivo. Although 
keratinocytes do not appear to express FN mRNA at any 
time, present methods have not yet permitted us to determine 
the respective roles played by individual inflammatory cells 
or dermal fibroblasts in producing the various types of FN 
synthesized during repair. Healing wounds are infiltrated by 
a heterogeneous population of inflammatory cells as well as 
by activated connective tissue cells. Methods for improving 
the preservation ftissue morphology to extend positive cell 
identification are currently under development. 
The demonstration that the pattern of FN splicing in the 
area of the healing wound is different from that in normal 
skin is a major finding of this study. In normal skin all FN 
mRNA appears to be EIIIA-, EIIIB-, but in wounds we 
found EIIIA ÷ and/or EIIIB ÷ FN mRNA localized to the 
wound base and edges at all stages after wounding. This is 
particularly interesting in light of our recent demonstration 
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that both EIIIA and EIIIB are included in the majority of the 
FN mRNA present in the early (embryonic days 2-4) 
chicken embryo (ffrench-Constant and Hynes, 1988), when 
there is active proliferation and migration of cells. However, 
the EIIIA and EIIIB regions are spliced out in tissue-specific 
patterns after embryogenesis and organogenesis have been 
largely completed (ffrench-Constant and Hynes, 1989). Al- 
though we have not examined embryonic rat FN mRNA 
directly, the patterns of FN splicing appear to be highly con- 
served among species; for example, hepatocytes synthesizing 
pFN and fibroblasts synthesizing cellular FN in culture show 
identical splicing patterns in chickens, rats, and humans 
(Schwarzbauer tal., 1983, 1987; Kornblihtt et al., 1985; 
Sekiguchi et al., 1986; Norton and Hynes, 1987). It there- 
fore seems likely that he early rat embryo, like the chicken, 
contains predominantly EIIIA ÷, EIIIB ÷ FN mRNA and that 
the results observed in this study reflect a reappearance of 
an embryonic pattern of FN splicing. Previous observations 
show that he pattern of FN mRNA splicing in cultured cells 
is accurately reflected in the FN synthesized by these cells 
(Tamkun and Hynes, 1983; Price and Hynes, 1985; Paul et 
al., 1986; Schwarzbauer tal., 1987). Therefore, our study 
provides evidence that splicing of FN mRNA during wound 
healing leads to different, and possibly functionally more ap- 
propriate, forms of FN than are present either from plasma 
or from nearby cells that do not alter their pattern of splicing 
from that seen in normal skin. 
Although these results do not address the actual func- 
tion(s) of the EIIIA ÷, EIIIB ÷ FN, the localization of this 
form of FN at the base and sides of the wound is consistent 
with a role in epithelial cell migration. In keeping with this, 
EIIIA +, EIIIB + FN is widespread in the embryo at a time 
when many different cell migrations are in progress (Norton 
and Hynes, 1987; ffrench-Constant and Hynes, 1988). How- 
ever, other functions for this form of FN such as a role in 
cell proliferation and differentiation r in chemotaxis obvi- 
ously should not be excluded. 
The mechanisms responsible for controlling the pattern of 
splicing change are unknown. However, TGF-/3, which in- 
creases the synthesis of both FN and its integrin receptor (Ig- 
notz et al., 1987; Ignotz and Massague, 1987; Raghow et al., 
1987; Roberts et al., 1988), has been shown by analyses of 
FN protein to increase the inclusion of EIIIA in FN (Baiza 
et al., 1988). This growth factor has been proposed to play 
an important role in wound healing, as the subcutaneous in-
jection of TGF-13 produces a cellular esponse which mimics 
the formation of granulation tissue found during wound heal- 
ing (Roberts et al., 1986). TGF-/3 is found in high concentra- 
tions in platelets (Assoian et al., 1983) and would therefore 
be expected to be released at the site of wounding, and TGF-/3 
mRNA has also been demonstrated in the macrophages pres- 
ent in a wound (Rappolee t al., 1988). It seems likely, there- 
fore, that this and other growth factors will be involved in 
the molecular and cellular mechanisms of healing and fur- 
ther in vitro studies of their role in the FN RNA splicing as- 
sociated with wound healing are clearly warranted. 
The finding that all detectable FN mRNA in normal skin 
was EIIIA-, EIIIB- was unexpected, as this pattern of FN 
splicing has been considered a characteristic ofpFN (Hynes, 
1985; Schwarzbauer tal., 1987; Gutman and Kornblihtt, 
1987; Zardi et al., 1987). Given the correlation between 
these in situ hybridization results and the pattern of FN label- 
ing using immunolocalization, it seems likely that EIIIA-, 
EIIIB- FN is synthesized in normal adult skin and depos- 
ited in the local matrix. This result raises the possibility that 
splicing of the V region, rather than of EIIIA or EIIIB, may 
represent an important difference between soluble pFN, syn- 
thesized in the liver, and locally produced "cellular" FN. V 
is included in only 50 % of pFN mRNA (Tamkun and Hynes, 
1983; Schwarzbauer t al., 1983, 1987; Paul and Hynes, 
1984; Paul et al., 1986; Norton and Hynes, 1987), whereas 
it appears to be present in the great majority of the FN 
mRNA present in embryos (Norton and Hynes, 1987; 
ffrench-Constant and Hynes, 1988). In addition, our quan- 
titative study of FN mRNA in 16-d chicken embryo using 
ribonuclease protection experiments found apparently com- 
plete V region inclusion in all tissues examined except he 
liver, which synthesizes pFN (ffrench-Constant and Hynes, 
1989). In this study, the level of inclusion of V95 appears to 
be high, as judged by labeling intensity (Figs. 2 and 7), al- 
though more quantitative analyses uch as nuclease protec- 
tion are needed to strengthen this conclusion. Further studies 
of V region splicing, and in particular of the V25 region 
which was not examined inour study but which can be alter- 
natively spliced in hepatocytes and fibroblasts (Paul et al., 
1986), are required to determine the contribution of this re- 
gion to the properties of FN. 
The synthesis of EIIIA +, EIIIB + "embryonic-type" FN af- 
ter wounding suggests that the EIIIA-, EIIIB- pFN, which 
is present as a result of exudation from damaged vessels and 
which represents he most abundant form of FN until at least 
the fourth day after wounding (Clark et al., 1983), may not 
be sufficient for satisfactory healing. This point has ther- 
apeutic implications, as a number of clinical trials have at- 
tempted to accelerate wound healing using exogenously ap- 
plied pFN (Clark, 1988; Grinnell et al., 1988). In light of 
our results, it seems likely that FN containing both EIIIA and 
EIIIB might provide the most efficient acceleration fwound 
repair. 
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